Eli N. Perencevich
Adjunct Associate Professor
Epidemiology & Public Health
100 N. Greene St.,
- B.S., Economics, University of Michigan, Ann Arbor
- M.D., Case Western Reserve University, Cleveland
- M.S., Epidemiology, Harvard School of Public Health, Cambridge, Massachusetts
- Internship and Residency in Medicine, The New York Hospital-Cornell Medical Center, New York, New York
- Chief Medical Resident, NYU Downtown Hospital, New York, New York
- Fellow, Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Dr. Perencevich is an infectious disease physician and epidemiologist studying emerging pathogens and nosocomial infections. His research focuses on the transmission dynamics of nosocomial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and vancomycin-resistant enterococci (VRE). He is particularly interested in identifying the most effective and cost-effective methods for controlling these pathogens. With David Hartley and Holly Gaff, he is working on mathematical models of MRSA transmission in ICU, hospital and city populations. In addition he is collaborating with Jon Furuno and Anthony Harris on developing prediction rules for cost-effective identification of MRSA and VRE carriage on hospital admission. He is currently funded through the VA Health Services Research & Development’s Advanced Career Development Award and a VA Merit award titled "Predicting Antibiotic Resistant Bacterial Carriage at Hospital Admission." Dr. Perencevich has over 50 publications in peer-reviewed journals and is lead author on a national guideline recommending methods for determining the economic impact of infection control interventions.
Current Grant Support:
Principal Investigator 9/30/08-9/30/10
“Automated methods for tracking compliance with infection control measures”
Association of American Medical Colleges – Centers for Disease Control and Prevention
CDC U36 CCU31927
Principal Investigator 9/1/06-8/30/09
“Predicting Antibiotic Resistant Bacteria Carriage at Hospital Admission.”
Department of Veterans Affairs, Health Services Research and Development
HSR&D VA Merit Award: IIR 04-123-2
"New nosocomial interventions to decrease antimicrobial resistance transmission"
Principle Investigator: Anthony Harris
Centers for Disease Control and Prevention
1 R01 CI000369-01
Wright MO, Hebden JN, Harris AD, Shanholtz CB, Standiford HC, Furuno JP, Perencevich EN. Aggressive Control Measures for Resistant Acinetobacter baumannii and the Impact on Acquisition of Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus in a Medical ICU. Infect Control Hosp Epi. 2004 Feb: 25(2):167-8.
Harris AD, Nemoy L, Johnson J, Carnahan AM, Smith DL, Perencevich EN. Co-carriage rates of VRE and ESBL-producing bacteria among a cohort of ICU patients: Implications for an Active Surveillance Program. Infect Control Hosp Epi 2004 Feb: 25(2): 105-8.
Perencevich EN, Kaye KS, Strausbaugh LJ, Fisman DN, Harris AD, and the Infectious Diseases Society of America Emerging Infections Network. Acceptable Treatment Failure Rates in Osteomyelitis Involving the Diabetic Foot: A Survey of Infectious Disease Physicians. Clin Infect Dis. 2004, Feb 15: 38(4): 476-82.
Smith DL, Dushoof J, Perencevich EN, Harris AD, Levin SA. Persistent Colonization and the Spread of Antibiotic Resistance in Nosocomial Pathogens: Resistance is a Regional Problem. Proc Natl Acad Sci U S A. 2004, Mar 9: 101(10):3709-3714.
Wright MO, Perencevich EN, Novak C, Hebden JN, Standiford HC, Harris AD. A Preliminary Assessment of an Automated Surveillance System for Infection Control; Infect Control Hosp Epi. 2004 Apr 25(4): 325-32.
Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, Smith DL. Projected Benefits of Active Surveillance for Vancomycin-Resistant Enterococci in ICU Settings. Clin Infect Dis. 2004, Apr 15: 38(8):1108-15.
Harris AD, Bradham DD, Mona Baumgarten M, Ilene H Zuckerman IH, Fink JC, Perencevich EN. The Use and Interpretation of Quasi-Experimental Studies in Infectious Diseases. Clin Infect Dis. 2004, Jun 1: 38(11):1586-91.
Furuno JP, Harris AD, Wright MO, McGregor JC, Venezia RA, Zhu J, Perencevich EN. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control, December 2004: 436-440.
Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X and Roghmann M. Risk of Mortality with a Bloodstream Infection is Higher in the Less Severely Ill at Admission. Am J Resp Crit Care Med. 2004 Dec 10.
Lautenbach E, Harris AD, Perencevich EN; Nachamkin I; Tolomeo P; Metlay JP. Test Characteristics of Peri-Rectal and Rectal Swab Compared to Stool Sample for Detection of Fluoroquinolone-Resistant Escherichia coli in the Gastrointestinal Tract. Antimicrob Agents Chemother. 2005, Feb;49(2):798-800.
Chan-Tack KM, Perencevich EN. Arcanum: Was This the Demise of the Food Critic? Clin Infect Dis 2005, Mar 1:40(5):754-5.
McGregor JC, Kim PW, Perencevich EN, Bradham DB, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD. The Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for use in Epidemiologic Studies of Antibiotic-Resistant Organisms. Am J Epidemiol. 2005 Mar 1;161(5):483-93.
Nemoy LL, Kotetishvili M, Tigno J, Keefer-Norris A, Harris AD, Perencevich EN, Johnson JA, Torpey D, Sulakvelidze A, Morris, Jr. JG, Stine OC. Multilocus Sequence Typing vs. Pulsed Field Gel Electrophoresis for the Characterization of Extended Spectrum Beta Lactamase Producing E. coli isolates. J Clin Micro, 2005 Apr;43(4):1776-81.
Harris AD, Carmeli Y, Samore MH, Kaye KS, Perencevich EN. Impact of selection bias and control group misclassification bias in case-control studies of antimicrobial-resistant organisms. Infect Control Hosp Epi, 2005 Apr 26(4): 342-45.
Harris AD, Lautenbach E, Perencevich EN. A Systematic Review of Quasi-Experimental Design Studies in Infection Control and Antibiotic Resistance. Clin Infect Dis. 2005 Jul 1;41(1):77-82
Perencevich EN, Hartley DM. Of Models and Methods: Our Analytic Armamentarium Applied to MRSA. Infect Control Hosp Epi, 2005 July 26(7)587-91.
Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Nemoy LL, Roghman M, Standiford HC, Hebden JN, Strauss SM, Harris AD. Patients at Risk for Vancomycin-Resistant Staphylococcus aureus: Co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. Oct 2005 11(10):1539-44.
Perencevich EN, Harris AD, Kaye KS, Bradham DD, Fisman DN, Liedtke LA, Strausbaugh LJ, Physicians’ Acceptable Treatment Failure Rates in Antibiotic Therapy for Coagulase-negative Staphylococcal Catheter-Associated Bacteremia: Implications for reducing treatment duration. Clin Infect Dis. 2005 Dec 15;41(12):1734-41.
Chan-Tack KM, Nemoy L, Perencevich EN. Central Venous Catheter-Associated Fungemia Secondary to Mucormycosis. Scandinavian J of Infect Dis 2005 Nov;37(11):925-927.
Whitcomb B, Pradhan EK, Pittas AG, Roghmann M, Perencevich EN. The association between hyperglycemia and mortality in different types of Intensive Care Units. Crit Care Med. 2005 Dec;33(12):2772-2777.
Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, McGregor JC, Zhu J, Perencevich EN. Population Antibiotic Susceptibility for Streptococcus pneumoniae and Treatment Outcomes in Common Respiratory Tract Infections. Pharmacoepidemiol Drug Saf. Pharmacoepidemiol Drug Saf. 2006 Jan;15(1):1-9.
Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson D, Finklestein J. The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics. J Am Med Inform Assoc. 2006 Jan-Feb;13(1):16-23.
Hartley DM, Furuno JP , Wright MO, Smith DL, Perencevich EN. The Role of Institutional Epidemiologic Weight in Guiding Infection Surveillance and Control in Community and Hospital Populations. Infect Control Hosp Epidemiol. 2006 Feb;27(2):170-4.
Furuno JP, McGregor JC, Harris AD, Johnson JA, Johnson JK, Langenberg P, Venezia RA, Finkelstein J, Smith DL, Strauss SM, Perencevich EN. Identifying High-Risk Groups for Carriage of Antibiotic-Resistant Bacteria. Arch Intern Med. Mar 13, 2006;166:580-585.
Johnson JK, Perencevich EN, Lincalis DP, Venezia RA. Dog Bite Transmission of Antibiotic Resistant Bacteria to a Human. Infect Control Hosp Epidemiol. 2006 Jul;27(7):762-3.
McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, Harris AD. Hospital Antimicrobial Stewardship Improved By A Computerized Clinical Decision Support System: A Patient-Randomized Controlled Trial. J Am Med Inform Assoc. 2006 Jul-Aug;13(4):378-84.
McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD. Development and validation of new comorbidity risk-adjustment measures for studies of antibiotic-resistant nosocomial infections. J Clin Epidemiol. 2006 Dec;59(12):1266-73.
Savel RH, Goldstein EB, Perencevich EN, Angood PB. The iCritical Care Podcast: a novel medium for critical care communication and education. J Am Med Inform Assoc. Jan 2007;14:94-99.
Osih R, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD. Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia. Antimicrob Agents Chemother. 2007 Mar;51(3):839-44.
Zuckerman IH, Perencevich EN, Harris AD. Concurrent Acute Illness and Comorbid Conditions Poorly Predict Antibiotic Use in Upper Respiratory Tract Infections: A Cross-Sectional Analysis. BMC Infect Dis 2007 May 30;7:47.
Schweitzer EJ, Perencevich EN, Bartlett ST. Estimated Benefits of Transplantation of Kidneys from Donors at Increased Risk for HIV or Hepatitis C Infection. Am J Transplant. Am J Transplant. 2007 Jun;7(6):1515-25.
Furuno JP, Harris AD, Wright MO, Hartley DM, McGregor, JC, Gaff HD, Hebden JN, Standiford HC, Perencevich EN. Value of Performing Active Surveillance Cultures on Intensive Care Unit Discharge for Detection of Methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. June 2007;28:666-670.
Wright MO, Furuno JP, Venezia RA, Johnson JK, Standiford HC, Hebden JN, Hill J, Hartley DM, Harris AD, Perencevich EN. Methicillin-resistant Staphylococcus aureus among hospitalized prisoners. Infect Control Hosp Epidemiol. 2007 Jul;28(7):877-9.
Green HP, Johnson JA, Furuno JP, Strauss SM, Perencevich EN, Lautenbach E, Lee D, Harris AD. Impact of Freezing on Future Utility of Archived Surveillance Cultures. Infect Control Hosp Epidemiol. 2007 Jul;28(7):886-8.
McGregor JC, Rich SA, Harris AD, Perencevich EN, Osih R, Lodise Jr. TP, Miller RR, Furuno JP. A Systematic Review of the Methods Used to Assess the Association Between Appropriate Antibiotic Therapy and Mortality in Bacteremic Patients. Clin Infect Dis 2007 Aug 1;45(3):329-37.
McGregor JC, Harris AD, Furuno JP, Bradham DD, Perencevich EN. Relative Influence of Antibiotic Therapy Attributes on Physician Choice in Treating Acute Uncomplicated Pyelonephritis. Med Decis Making 2007;27(4):387-394
Shardell S, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis of quasi-experiments and their application to antimicrobial resistance intervention studies. Clin Infect Dis. 2007 Oct 1;45(7):901-7.
Thom KA, Johnson JA, Straus SM, Furuno JP, Perencevich EN, Harris AD. Increasing Prevalence of Gastrointestinal Colonization with Ceftazidime-resistant Gram-negative Bacteria among Intensive Care Patients. Infect Control Hosp Epidemiol 2007 Nov;28(11):1240-6.
Harris AD, Perencevich EN, Johnson JK, Paterson DL, Morris JG, Strauss SM, Johnson JJ. Patient-to-Patient Transmission is Important in Extended Spectrum beta-Lactamase-Producing Klebsiella pneumoniae Acquisition. Clin Infect Dis, Nov 15 2007;45:1347-1350.
Kaye KS, Harris AD, McDonald JR, Strausbaugh LJ, Sexton DJ, Perencevich, EN. Measuring Acceptable Treatment Failure Rates in Community-Acquired Pneumonia: Potential for Reducing Treatment Duration and Antimicrobial Resistance. Infect Control Hosp Epidemiol 2008 Feb;29(2):137-142.
Furuno JP, Schweizer ML, McGregor JC, Perencevich EN. Economics of Infection Control Surveillance Technology: Cost-effective or Just Cost? Am J Infect Control 2008 Apr 36(3) S12-17.
Lautenbach E, Santana E, Lee A, Tolomeo P, Babson A, Perencevich EN. Harris AD, Smith CA, Maslow J. Efficient Recovery of Fluoroquinolone-Susceptible and Fluoroquinolone-Resistant Escherichia coli Strains Obtained From Frozen Cultures. Infect Control Hosp Epidemiol 2008 Apr; 29(4):367-9
Snyder GM, Thom KA, Furuno JP, Perencevich EN, Roghmann MC, Johnson JA, Strauss SM, Netzer G, Harris AD. Detection of Methicillin-resistant Staphylococcus aureus* and Vancomycin-resistant Enterococci by Healthcare Workers on Infection Control Gown and Gloves. Infect Control Hosp Epidemiol. 2008 Jul;29(7):583-589.
Thom K, Schweizer M, Osih R, McGregor J, Furuno J, Perencevich E, Harris A. Clinical Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia. BMC Infectious Disease. 2008 Sep 15;8(1):116.
Furuno JP, Hebden JN, Standiford HC, Perencevich EN, Miller RR, Moore AC, Strauss SM, Harris AD. Prevalence of Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii at a Long-term Acute-care Facility. Am J Infect Control. 2008 Sep;36(7):468-471
Perencevich EN, Thom KA. (Invited Editorial) Preventing Clostridium difficile-associated disease: Is it time to pay the piper? Infect Control Hosp Epidemiol. 2008 Sep;29(9):829-831
Schweizer ML, Furuno JP, Harris AD, McGregor JC, Thom KA, Johnson JK, Shardell MD, Perencevich EN. Clinical Utility of Infection Control Documentation of Prior History of Methicillin-resistant Staphylococcus aureus Colonization or Infection. Infect Control Hosp Epidemiol. 2008 Oct;29(10):972-4.
Maragakis LL, Perencevich EN, Cosgrove SE. The Clinical and Economic Burden of Antimicrobial Resistance. Expert Review of Anti-infective Therapy. Expert Rev Anti Infect Ther. 2008 Oct;6(5):751-763.
Munivenkatappa RB, Papadimitriou JC, Drachenberg CB, Schweitzer EJ, Thom KA, Perencevich EN, Haririan A, Rasetto F, Cooper M, Campos L, Barth RN, Bartlett ST, Philosophe B. The Maryland Aggregate Pathology Index (MAPI). A Deceased Donor Kidney Biopsy Scoring System for Predicting Graft Failure. Am J Transplant. 2008 Nov;8(11):2316-24
Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG, Fisman DN, Johnson JA. Summer Peaks in Gram-Negative Bacterial Infections among Hospitalized Patients. Infect Control Hosp Epidemiol 2008 Dec;29(12):1124-31
Treakle A, Thom KA, Furuno JP, Strauss SM, Johnson JA, Harris AD, Perencevich EN. Bacterial Contamination of Healthcare Workers' White Coats. Am J Infect Control (in press)
Duke-Sylvester SM, Perencevich EN, Furuno JP, Real LA, Gaff HD. Advancing epidemiological science through computational modeling. Annales Zoologici Fennici (in press)
Morgan DJ, Sepkowitz KA, Diekema D, Perencevich EN. The evidence for adverse outcomes associated with contact isolation. Am J Infect Control (in press)
Perencevich EN, Harris AD. “Evidence Based Infection Control” in the British Medical Journal’s Evidence Based Infectious Disease, BMJ, London, May 7, 2004.
Perencevich EN, Perl TP. “Enterococcal Infections” in Cecil Textbook of Medicine, 23rd Edition; Editors L. Goldman and D. Ausiello.. Saunders Elsevier, Philadelphia, PA. 2008.
Cosgrove CE, Perencevich EN. “Economic Evaluation of Healthcare-associated Infections and Infection Control Interventions” in Bennett & Brachman's Hospital Infections, 5th Edition; Editor: William Jarvis, Sept 1, 2007.
Snyder GM, Perencevich EN, Harris AD. “Evidence Based Infection Control” in the British Medical Journal’s Evidence Based Infectious Disease, BMJ, London, (in press).